Skip to content

Clinical study on the treatment of lumber disc herniation with tituo point loosening meridians tuina manipulation

Clinical study on the treatment of lumber disc herniation with tituo point loosening meridians tuina manipulation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074068
Enrollment
Unknown
Registered
2023-07-28
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumber disc herniation

Interventions

Observation group:tituo point loosening meridians tuina manipulation
Control group:Conventional means

Sponsors

Wang Jing Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1 Patients aged 18-65 years old, male or female. 2 Meet the diagnostic criteria for lumbar disc herniation: 3 Imaging showed that the compression segment was L4/L5 or L5/S1 and showed corresponding symptoms of nerve root compression. 4. Patients who have not been treated by other means or taken other drugs in the past 1 month.

Exclusion criteria

Exclusion criteria: ?Patients with serious cardiovascular diseases (such as myocardial infarction, severe heart failure, etc.), lung diseases (such as pulmonary insufficiency, etc.), Kidney disease, liver disease, hematopoietic system and other diseases; ?Patients with moderate to severe osteoporosis, fracture or other manipulation contraindications; ?Lumbar instability, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar tuberculosis, femoral head necrosis, vascular diseases, tumors, great nucleus pulposus herniation leading to severe neurological impairment, extreme lateral protrusion leading to severe radiating pain of lower limb, cauda equina syndrome, or have other diseases that require surgery; ?NSAIDs or neurotrophic drugs have been used within 2 weeks (except for stable medical treatment recurrence of more than 2 weeks); ?Pregnant women or breastfeeding women; ?The mentally ill; ?Participants who are participating in other clinical drug trials at the same time.

Design outcomes

Primary

MeasureTime frame
VAS score for low back pain;

Secondary

MeasureTime frame
Patient reported outcomes Scale;sEMG of vertical spinal muscle;

Countries

China

Contacts

Public ContactZhang Zhaojie

Wang Jing Hospital of China Academy of Chinese Medical Sciences

zhangzhaojie2010@163.com+86 136 8331 1461

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026